Smith & Nephew merger talks with J&J orthopaedics unit collapse over CEO role
JNJ•A deal to combine Johnson & Johnson’s orthopaedics business with Smith & Nephew and create a $34 billion medical technology company reportedly unravelled after Smith & Nephew refused to agree to its former CEO leading the merged business.
1. Talks collapse
A deal to combine Johnson & Johnson’s orthopaedics business with Smith & Nephew and create a $34 billion transatlantic medical technology company unravelled after Smith & Nephew refused to agree to its former CEO leading the merged business, the Financial Times reported. Reuters said it could not immediately verify the report.
